In-vitro studies on cell cultures of humans and mice somatotropinomas provided encouraging results on the use of mTOR inhibitors, with the reduction of GH secretion and the induction of cell death [113, 117, 119]. The gene discussed is GH1; the disease is growth hormone-producing pituitary gland neoplasm.